Chris Dall | News Reporter | CIDRAP NewsApr 15, 2020Scientists are sifting through which of dozens of serologic tests are going to be useful for assessing how many people have been exposed. But only one test has been reviewed by the FDA.
Antibody tests may hold clues to COVID-19 exposure, immunity—but it’s complicated
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows